Narcolepsy: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• GLP-1 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 170 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

  NCT06179407· Merck Sharp & Dohme LLC· Updated 14 Apr 2026

  “Terminated for business reasons”Registry text, quoted unchanged. Source

• Terminated

  A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

  NCT06961266· Jazz Pharmaceuticals· Updated 6 Apr 2026

  “The study was terminated based on a business decision by the Sponsor.”Registry text, quoted unchanged. Source

• Withdrawn

  Feasibility Study of At-Home EEG Monitoring for Hypersomnia

  NCT05627388· Kaiser Permanente· Updated 14 May 2024

  “Study was never started. The research protocol was redeveloped and submitted as a new study therefore we would like to close this study.”Registry text, quoted unchanged. Source

• Terminated

  The Nuvigil and Provigil Pregnancy Registry

  NCT01792583· Cephalon, Inc.· Updated 5 Feb 2024

  “The study is no longer feasible.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study to Investigate the Effects of Cleminorexton Compared with Placebo in the Treatment of Participants with Central Disorders of Hypersomnolence

  2026-525961-37-00· Centessa Pharmaceuticals UK Limited· Source

• A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

  NCT07646678· Takeda· Source

• Epidemiology of Narcolepsy Type 1 and Type 2 in Spain

  NCT07299097· Takeda· Source

• A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

  NCT07363720· Takeda· Source

• A Study About Treatment Use in Adults With Narcolepsy Type 1 (NT1) in Europe and Canada

  NCT07903220· Takeda· Source

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

  NCT01793168· Sanford Health· Source

• Ofatumumab in Treatment-Refractory¬ Narcolepsy Type 1

  NCT07871006· Xijing Hospital· Source

• A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

  NCT06952699· Takeda· Source

• A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

  NCT07625280· Jazz Pharmaceuticals· Source

• A Trial to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy.

  2025-523503-30-00· Eisai Limited· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Mendelian Randomization Analysis 3
• Gene Expression Profiling 2
• Proteomics 1
• Magnetic Resonance Imaging 5
• Machine Learning 3
• Deep Learning 1
• Cohort Studies 11
• Genome-Wide Association Study 2

• The German version of the Sleep Inertia Questionnaire in central disorders of hypersomnolence: a validation study.

  Sleep Med, Sept 2026

• Candidate biomarkers in narcolepsy in H1N1-vaccinated cohorts: A proteomic and transcriptomic study.

  Sleep Med, Sept 2026

• Hypothalamic volume reduction in adult patients with narcolepsy type 1.

  Sleep, Jun 2026

• Assessing the Risk of Adverse Maternal and Infant Outcomes Following Prenatal Modafinil Exposure: A French Nationwide Cohort Study.

  Drug Saf, Jun 2026

• Progressive Orexin Deficiency and Age-Dependent Glial and Axonal Biomarkers in juvenile neuronal ceroid lipofuscinosis type 3 (CLN3) Disease.

  Pediatr Neurol, May 2026

• Mortality in narcolepsy and other sleep clinic patients: a 25-year propensity-matched VA cohort study.

  J Clin Sleep Med, May 2026

• Cardiovascular risk in narcolepsy: Comparison of type 1 and type 2 in a real-world cohort.

  J Clin Sleep Med, Apr 2026

• Sensor-Based Assessment of Morning Prospective Memory in Narcolepsy Type 1: Evidence from Children and Adult Cohorts.

  Sensors (Basel), Apr 2026

• Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary Results from the DUET Study.

  CNS Drugs, Mar 2026

• iSPHYNCS: Unsupervised Clustering in Questionnaires and Metadata Reveals Distinct Subtypes in the Narcolepsy Borderland.

  J Sleep Res, Feb 2026

See which targets of this disease your abstract mentions, and go to the people working on them.